|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
142 a.a.
|
 |
|
|
|
|
|
|
|
254 a.a.
|
 |
|
|
|
|
|
|
|
191 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
_CA
×6
|
 |
|
|
|
|
|
|
|
_CL
×3
|
 |
|
|
|
|
|
|
|
_MG
×3
|
 |
|
|
|
|
|
|
|
_NA
|
 |
|
|
|
|
|
|
|
_ZN
×2
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/blood clotting
|
 |
|
Title:
|
 |
Complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+
|
|
Structure:
|
 |
Coagulation factor vii. Chain: l. Fragment: light chain, residues 61-212. Synonym: serum prothrombin conversion accelerator, spca, proconvertin, eptacog alfa. Engineered: yes. Coagulation factor vii. Chain: h. Fragment: heavy chain, residues 213-466.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: f7. Expressed in: mesocricetus auratus. Expression_system_taxid: 10036. Expression_system_cell_line: bhk. Other_details: plasmid. Gene: f3.
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.198
|
R-free:
|
0.259
|
|
|
Authors:
|
 |
S.P.Bajaj,M.Bajaj,A.E.Schmidt,K.Padmanabhan
|
Key ref:
|
 |
S.P.Bajaj
et al.
(2006).
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.
J Biol Chem,
281,
24873-24888.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
22-Jun-05
|
Release date:
|
04-Jul-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P08709
(FA7_HUMAN) -
Coagulation factor VII from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
466 a.a.
142 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.21
- coagulation factor VIIa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolyzes one Arg-|-Ile bond in factor X to form factor Xa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
281:24873-24888
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.
|
|
S.P.Bajaj,
A.E.Schmidt,
S.Agah,
M.S.Bajaj,
K.Padmanabhan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Factor VIIa (FVIIa) consists of a gamma-carboxyglutamic acid (Gla) domain, two
epidermal growth factor-like domains, and a protease domain. FVIIa binds seven
Ca(2+) ions in the Gla, one in the EGF1, and one in the protease domain.
However, blood contains both Ca(2+) and Mg(2+), and the Ca(2+) sites in FVIIa
that could be specifically occupied by Mg(2+) are unknown. Furthermore, FVIIa
contains a Na(+) and two Zn(2+) sites, but ligands for these cations are
undefined. We obtained p-aminobenzamidine-VIIa/soluble tissue factor (sTF)
crystals under conditions containing Ca(2+), Mg(2+), Na(+), and Zn(2+). The
crystal diffracted to 1.8A resolution, and the final structure has an R-factor
of 19.8%. In this structure, the Gla domain has four Ca(2+) and three bound
Mg(2+). The EGF1 domain contains one Ca(2+) site, and the protease domain
contains one Ca(2+), one Na(+), and two Zn(2+) sites. (45)Ca(2+) binding in the
presence/absence of Mg(2+) to FVIIa, Gla-domainless FVIIa, and prothrombin
fragment 1 supports the crystal data. Furthermore, unlike in other serine
proteases, the amide N of Gly(193) in FVIIa points away from the oxyanion hole
in this structure. Importantly, the oxyanion hole is also absent in the
benzamidine-FVIIa/sTF structure at 1.87A resolution. However, soaking
benzamidine-FVIIa/sTF crystals with d-Phe-Pro-Arg-chloromethyl ketone results in
benzamidine displacement, d-Phe-Pro-Arg incorporation, and oxyanion hole
formation by a flip of the 192-193 peptide bond in FVIIa. Thus, it is the
substrate and not the TF binding that induces oxyanion hole formation and
functional active site geometry in FVIIa. Absence of oxyanion hole is unusual
and has biologic implications for FVIIa macromolecular substrate specificity and
catalysis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIGURE 2. Conformation of the loop and positions of
the Ca^2^+ and Mg^2^+ ions in the FVIIa Gla domain. A,
superpositioning of the Gla domain in the presence of
Ca^2+/Mg^2+ versus Ca^2+ (19). The C atoms used for
superpositioning were residues 13L-46L. The Ca^2+/Mg^2+
structure is in blue and the Ca^2+ structure is in magenta.
Phe^4, Leu^5, Gla6, Gla7, and Leu^8 are depicted for both
structures. Ca^2+ (blue) and Mg^2+ (cyan) ions for the present
structure as well as Ca^2+ ions (magenta) for the PDB code 1DAN
(19) are shown as spheres. N represents the N terminus of the
Gla domain of FVIIa. B, coordination of the Ca^2+ and Mg^2+ ions
in the Gla domain of the Ca^2+/Mg^2+ structure. Electron density
(2F[obs] - F[calc]) contoured at 1 of all nine Gla
residues as well as that of Ca^2+ (magenta spheres), Mg^2+ (cyan
spheres), and coordinating water molecules (red spheres)is
shown. Coordination of Ca5 to O of Ala^1L and H-bonds between
Gla6 and the NH[2] side chain of Arg^9L, Gla7, and NofPhe^4L,
and a water molecule with O [1] of Gln^2L are
indicated with dashed arrows. Black dashed lines depict all
other coordinations and H-bonds. A stereo figure is given in the
supplemental material as Fig. 1S.
|
 |
Figure 5.
FIGURE 5. Ca^2^+ site in the EGF1 domain and location of
the Zn^2^+ sites and their linkage to the protease domain Ca^2^+
site in FVIIa. A, Ca^2+ site in the EGF1 domain. Electron
density (2F[obs] - F[calc]) contoured at 1 (gray) for Ca^2+
(magenta sphere) and two water molecules (red spheres) is shown.
Electron density contoured at 5 for Ca^2+ is shown in
blue. Note that in the presence of Ca^2+, Mg^2+ will not occupy
this site. All eight coordination ligands (black dashed lines)
are shown, and the residues labeled are those of the light chain
of FVIIa. B, location of the Zn^2+ sites and their linkage to
the protease domain Ca^2+ site. Electron density (2F[obs] -
F[calc]) contoured at 1 (gray) of Zn^2+ (cyan
spheres), Ca^2+ (magenta sphere), and water molecules (red
spheres) is shown. The electron density contoured at 3 for
Zn^2+ and Ca^2+ ions is shown in blue. Note the linkage between
the Zn^2+ sites and the Ca^2+ site. The metal ion coordination
to its ligands and H-bonds between water molecules is shown with
black dotted lines. Residue numbering used in the figure is that
of chymotrypsin.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2006,
281,
24873-24888)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.S.Craik,
M.J.Page,
and
E.L.Madison
(2011).
Proteases as therapeutics.
|
| |
Biochem J,
435,
1.
|
 |
|
|
|
|
 |
S.Rana,
N.Pozzi,
L.A.Pelc,
and
E.Di Cera
(2011).
Redesigning allosteric activation in an enzyme.
|
| |
Proc Natl Acad Sci U S A,
108,
5221-5225.
|
 |
|
|
|
|
 |
A.D.Vogt,
A.Bah,
and
E.Di Cera
(2010).
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.
|
| |
J Phys Chem B,
114,
16125-16130.
|
 |
|
|
|
|
 |
A.Raturi,
and
W.Ruf
(2010).
Effect of protein disulfide isomerase chaperone activity inhibition on tissue factor activity.
|
| |
J Thromb Haemost,
8,
1863-1865.
|
 |
|
|
|
|
 |
B.de Courcy,
L.G.Pedersen,
O.Parisel,
N.Gresh,
B.Silvi,
J.Pilmé,
and
J.P.Piquemal
(2010).
Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks.
|
| |
J Chem Theory Comput,
6,
1048-1063.
|
 |
|
|
|
|
 |
C.J.Lee,
V.Chandrasekaran,
S.Wu,
R.E.Duke,
and
L.G.Pedersen
(2010).
Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.
|
| |
Thromb Res,
125,
S7.
|
 |
|
|
|
|
 |
Z.Chen,
L.A.Pelc,
and
E.Di Cera
(2010).
Crystal structure of prethrombin-1.
|
| |
Proc Natl Acad Sci U S A,
107,
19278-19283.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.S.Messer,
W.H.Velander,
and
S.P.Bajaj
(2009).
Contribution of magnesium in binding of factor IXa to the phospholipid surface: implications for vitamin K-dependent coagulation proteins.
|
| |
J Thromb Haemost,
7,
2151-2153.
|
 |
|
|
|
|
 |
E.Persson,
and
O.H.Olsen
(2009).
Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
|
| |
FEBS J,
276,
3099-3109.
|
 |
|
|
|
|
 |
M.J.Heeb,
D.Prashun,
J.H.Griffin,
and
B.N.Bouma
(2009).
Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
|
| |
FASEB J,
23,
2244-2253.
|
 |
|
|
|
|
 |
S.Agah,
and
S.P.Bajaj
(2009).
Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium.
|
| |
J Thromb Haemost,
7,
1426-1428.
|
 |
|
|
|
|
 |
W.Niu,
Z.Chen,
L.A.Bush-Pelc,
A.Bah,
P.S.Gandhi,
and
E.Di Cera
(2009).
Mutant N143P reveals how Na+ activates thrombin.
|
| |
J Biol Chem,
284,
36175-36185.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.E.Schmidt,
M.F.Sun,
T.Ogawa,
S.P.Bajaj,
and
D.Gailani
(2008).
Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
|
| |
Biochemistry,
47,
1326-1335.
|
 |
|
|
|
|
 |
C.J.Farady,
P.F.Egea,
E.L.Schneider,
M.R.Darragh,
and
C.S.Craik
(2008).
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.
|
| |
J Mol Biol,
380,
351-360.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Di Cera
(2008).
Thrombin.
|
| |
Mol Aspects Med,
29,
203-254.
|
 |
|
|
|
|
 |
M.E.Papaconstantinou,
P.S.Gandhi,
Z.Chen,
A.Bah,
and
E.Di Cera
(2008).
Na+ binding to meizothrombin desF1.
|
| |
Cell Mol Life Sci,
65,
3688-3697.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Hacisalihoglu,
P.Panizzi,
P.E.Bock,
R.M.Camire,
and
S.Krishnaswamy
(2007).
Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.
|
| |
J Biol Chem,
282,
32974-32982.
|
 |
|
|
|
|
 |
E.Di Cera,
M.J.Page,
A.Bah,
L.A.Bush-Pelc,
and
L.C.Garvey
(2007).
Thrombin allostery.
|
| |
Phys Chem Chem Phys,
9,
1291-1306.
|
 |
|
|
|
|
 |
E.Persson,
and
A.Ostergaard
(2007).
Mg(2+) binding to the Gla domain of factor X influences the interaction with tissue factor.
|
| |
J Thromb Haemost,
5,
1977-1978.
|
 |
|
|
|
|
 |
O.H.Olsen,
K.D.Rand,
H.Østergaard,
and
E.Persson
(2007).
A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulation.
|
| |
Protein Sci,
16,
671-682.
|
 |
|
|
|
|
 |
P.E.Bock,
P.Panizzi,
and
I.M.Verhamme
(2007).
Exosites in the substrate specificity of blood coagulation reactions.
|
| |
J Thromb Haemost,
5,
81-94.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2007).
Survey of the year 2006 commercial optical biosensor literature.
|
| |
J Mol Recognit,
20,
300-366.
|
 |
|
|
|
|
 |
V.M.Chen,
and
P.J.Hogg
(2006).
Allosteric disulfide bonds in thrombosis and thrombolysis.
|
| |
J Thromb Haemost,
4,
2533-2541.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|